BioNTech Says Making More Covid-19 Doses Depends on Many Factors

The transcript discusses the development and testing of vaccines against new coronavirus variants, emphasizing the adaptability of mRNA technology. It covers production expansion plans, logistics, and distribution challenges, as well as the goal of achieving global vaccine access. The adaptability of mRNA vaccines to new strains is highlighted as a significant advantage.

What is the target number of vaccine doses Beyond Tech aims to produce in 2021?

How does the design of the vaccine allow for calibration to different strains of the coronavirus?

What advantages does the mRNA technology provide in the context of vaccine development?